# Coherus Oncology, Inc.

Canonical: https://abierto.us/vendors/coherus-oncology-inc-v13jdmamelk8

- UEI: V13JDMAMELK8
- CAGE: 88J79
- Location: Redwood City, CA
- Awards in window: 3 (22 transactions), $19,420,700 obligated, February 2, 2024 to September 2, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $19,420,700
- Department of Veterans Affairs: 2 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $19,420,700

## Competition

- Full and Open Competition: 3 awards

## Solicitations won

- Pegfilgrastim 6MG/.06ML with VMI (75A50324R00004), $45,162,200. https://abierto.us/opportunities/75a50324r00004
- PegFilgrastim April 11, 2025 - April 10, 2026 (36E79725R0001), $27,626,788. https://abierto.us/opportunities/36e79725r0001

## Largest awards

- 75A50325C00002 (definitive contract): $19,420,700, Aspr/Orm-Sns. Pegfilgrastim 6mg/.06ml (Inj, Soln, Syr or Autoinjector) and Vmi. https://www.usaspending.gov/award/CONT_AWD_75A50325C00002_7505_-NONE-_-NONE-/
- 36E79725D0014: $0, Nac Pharmaceuticals. New Award for Pegfilgrastim with Coherus Biosciences, INC. Ordering Period Is April 11, 2025, to April 10, 2026, with Four ONE-YEAR Options.. https://www.usaspending.gov/award/CONT_IDV_36E79725D0014_3600/
- 36F79719D0216: $0, Nac Federal Supply Schedule. ADD-PROV Stage. https://www.usaspending.gov/award/CONT_IDV_36F79719D0216_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/coherus-oncology-inc-v13jdmamelk8.